Figure 3. Inhibition of Neutrophil Elastase by Heparan Sulfate.
A. Space filling structures for human neutrophil elastase based on the solved X-ray crystal structure 1HNE [109], and for a heparin-derived dodecasaccharide based on NMR analysis (1HPN) [110]. B. The relative rate of human neutrophil elastase digestion of a pseudosubstrate N-Suc-(Ala)3-pNA in the presence of the indicated heparin-derived oligosaccharide. Degree of polymerization is indicated on the x-axis. Reactions were carried out for 1 h at 27°C. Experimental details of elastase enzyme assay conditions are described in [71].